Report of the Texas State Auditor's Office related to performance measure certification, quality assurance team reviews, and information system vulnerability assessments of the University of Texas M.D. Anderson Cancer Center.
This unique book provides a retrospective analysis of the changes in survival outcomes at the University of Texas, M.D. Anderson Cancer Center over the past six decades. Since opening its doors in 1944, M.D. Anderson has kept a continuous, uninterrupted data repository of the treatment and outcomes of each of its patients. It is this visionary database from the center's tumor registry which makes this groundbreaking book possible. Tracking results across time, this book shows radical shifts in outcomes trends, where great progress has been made, and where there is still a long way to go, and o
Zugriffsoptionen:
Die folgenden Links führen aus den jeweiligen lokalen Bibliotheken zum Volltext:
At the heart of Houston stands the Texas Medical Center. This dense complex of educational, clinical, and hospital facilities offers state-of-the-art patient care, basic science, and applied research in more than fifty medicine-related institutions. Three medical schools, four schools of nursing, and schools of dentistry, public health, and pharmacology occupy the thousand-acre campus. But none of this would exist if not for the generosity and vision of Monroe Dunaway Anderson, who, in 1936, established the foundation that bears his name. The M.D. Anderson Foundation ultimatel
Verfügbarkeit an Ihrem Standort wird überprüft
Dieses Buch ist auch in Ihrer Bibliothek verfügbar:
Major Topics Covered: Personal and educational background Military experience and impact on leadership The Cancer Biology Program Building multi-disciplinary research at MD Anderson Creating multi-disciplinary education at MD Anderson The Office of Academic Affairs ; https://openworks.mdanderson.org/mchv_interviewsessions/1000/thumbnail.jpg
Major Topics Covered: Sources of land for MD Anderson Research Park in Smithville and Bastrop, Texas Legislators and others instrumental in advocating in the Legislature R. Lee Clark's vision for a research facility; personal motives for locating the facility outside of Houston Local and governmental considerations in approving land for a laboratory ; https://openworks.mdanderson.org/mchv_interviewsessions/1036/thumbnail.jpg
Major Topics Covered: Educational background and military experience Development of interest in pediatric cancer The two-hit model: discovery and implications Mentoring and advice for young scientists The Graduate School of Biomedical Science: history, effects Personal characteristics Perspectives on the fields of cancer biology and neuroscience ; https://openworks.mdanderson.org/mchv_interviewsessions/1053/thumbnail.jpg
Major Topics Covered: Research: the continuous flow-blood separator; innovations in chemotherapy and combination therapy ; Collaborations with Dr. Emil Frei, III; The Department of Developmental Therapeutics; Building the culture of clinical research; training clinical researchers and physician-scientists ; History of cancer medicine, clinical research, translational research and education; Institutional politics as they influenced: Developmental Therapeutics, individual investigators, the standing of clinical research, the education of physician scientists; ; https://openworks.mdanderson.org/mchv_interviewsessions/1023/thumbnail.jpg
Major Topics Covered: The Department of Developmental Therapeutics; Building the culture of clinical research; training clinical researchers and physician-scientists ; MD Anderson presidents and the history and expansion of MD Anderson ; Institutional politics as they influenced: Developmental Therapeutics, individual investigators, the standing of clinical research, the education of physician scientists; The ethics of clinical research ; https://openworks.mdanderson.org/mchv_interviewsessions/1024/thumbnail.jpg
Major Topics Covered: The Department of Developmental Therapeutics; Building the culture of clinical research; training clinical researchers and physician-scientists ; MD Anderson presidents and the history and expansion of MD Anderson Institutional politics as they influenced: Developmental Therapeutics, individual investigators, the standing of clinical research, the education of physician scientists; The ethics of clinical research ; https://openworks.mdanderson.org/mchv_interviewsessions/1025/thumbnail.jpg
Intro -- Contents -- Preface -- Acknowledgments -- CHAPTER 1 R. Lee Clark, History, and the Dread Disease -- CHAPTER 2 Present at the Creation -- CHAPTER 3 Designing a Dream, 1946-1950 -- CHAPTER 4 The Pink Palace, 1950-1955 -- CHAPTER 5 Changing Paradigms, 1956-1963 -- CHAPTER 6 M. D. Anderson and the Rise of Medical Oncology, 1964-1969 -- CHAPTER 7 The Summit, 1970-1971 -- CHAPTER 8 Waging War and Fading Away, 1971-1977 -- CHAPTER 9 Charles A. LeMaistre and the Consolidation of Excellence, 1978-1983 -- CHAPTER 10 Chasing the Devil, 1984-1988 -- CHAPTER 11 Victory, Defeat, and an Elusive Enemy, 1988-1996 -- CHAPTER 12 John Mendelsohn and the New Frontiers in Oncology, 1996-2000 -- CHAPTER 13 New Offensives, 2001-2007 -- CHAPTER 14 Tipping History? -- Epilogue -- Notes -- Bibliography -- Index -- A -- B -- C -- D -- E -- F -- G -- H -- I -- J -- K -- L -- M -- N -- O -- P -- Q -- R -- S -- T -- U -- V -- W -- Y -- Z -- Illustrations.
Zugriffsoptionen:
Die folgenden Links führen aus den jeweiligen lokalen Bibliotheken zum Volltext:
Bill introduced by the Texas Senate relating to a contract for the acquisition of goods or services to which The University of Texas M. D. Anderson Cancer Center is a party.
Report of the Texas State Auditor's Office related to the accreditation review for the Texas A&M University System Health Science Center in fiscal year 2002.
International audience ; In 2006, a remarkable collaboration between University of Texas MD Anderson Cancer Center clinicians andTexas and New Mexico State legislators led to the formation of a dedicated IBC Research Program and Clinicat MD Anderson. This initiative provided funding and infrastructure to foster coordination of an IBC WorldConsortium of national and international experts, and launch the first ever IBC international conference in2008, which brought together experts from around the world to facilitate collaborations and accelerateprogress. Indeed great progress has been made since then. National and international experts in IBCconvened at the 10th Anniversary Conference of the MD Anderson IBC Clinic and Research Program andpresented the most extensive sequencing analysis to date comparing IBC to non-IBC, gene- andprotein-based immunoprofiling of IBC versus non-IBC patients, and converging lines of evidence on thespecific role of the microenvironment in IBC. Novel models, unique metabolic mechanisms, and prominentsurvival pathways have been identified and were presented. Multiple clinical trials based on the work of thelast decade are in progress or in development. The important challenges ahead were discussed. This progressand a coordinated summary of these works are presented herein.
International audience ; In 2006, a remarkable collaboration between University of Texas MD Anderson Cancer Center clinicians andTexas and New Mexico State legislators led to the formation of a dedicated IBC Research Program and Clinicat MD Anderson. This initiative provided funding and infrastructure to foster coordination of an IBC WorldConsortium of national and international experts, and launch the first ever IBC international conference in2008, which brought together experts from around the world to facilitate collaborations and accelerateprogress. Indeed great progress has been made since then. National and international experts in IBCconvened at the 10th Anniversary Conference of the MD Anderson IBC Clinic and Research Program andpresented the most extensive sequencing analysis to date comparing IBC to non-IBC, gene- andprotein-based immunoprofiling of IBC versus non-IBC patients, and converging lines of evidence on thespecific role of the microenvironment in IBC. Novel models, unique metabolic mechanisms, and prominentsurvival pathways have been identified and were presented. Multiple clinical trials based on the work of thelast decade are in progress or in development. The important challenges ahead were discussed. This progressand a coordinated summary of these works are presented herein.